Combinatorial prediction of therapeutic perturbations using causally inspired neural networks

IF 26.8 1区 医学 Q1 ENGINEERING, BIOMEDICAL
Guadalupe Gonzalez, Xiang Lin, Isuru Herath, Kirill Veselkov, Michael Bronstein, Marinka Zitnik
{"title":"Combinatorial prediction of therapeutic perturbations using causally inspired neural networks","authors":"Guadalupe Gonzalez, Xiang Lin, Isuru Herath, Kirill Veselkov, Michael Bronstein, Marinka Zitnik","doi":"10.1038/s41551-025-01481-x","DOIUrl":null,"url":null,"abstract":"<p>Phenotype-driven approaches identify disease-counteracting compounds by analysing the phenotypic signatures that distinguish diseased from healthy states. Here we introduce PDGrapher, a causally inspired graph neural network model that predicts combinatorial perturbagens (sets of therapeutic targets) capable of reversing disease phenotypes. Unlike methods that learn how perturbations alter phenotypes, PDGrapher solves the inverse problem and predicts the perturbagens needed to achieve a desired response by embedding disease cell states into networks, learning a latent representation of these states, and identifying optimal combinatorial perturbations. In experiments in nine cell lines with chemical perturbations, PDGrapher identifies effective perturbagens in more testing samples than competing methods. It also shows competitive performance on ten genetic perturbation datasets. An advantage of PDGrapher is its direct prediction, in contrast to the indirect and computationally intensive approach common in phenotype-driven models. It trains up to 25× faster than existing methods, providing a fast approach for identifying therapeutic perturbations and advancing phenotype-driven drug discovery.</p>","PeriodicalId":19063,"journal":{"name":"Nature Biomedical Engineering","volume":"16 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Biomedical Engineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1038/s41551-025-01481-x","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Phenotype-driven approaches identify disease-counteracting compounds by analysing the phenotypic signatures that distinguish diseased from healthy states. Here we introduce PDGrapher, a causally inspired graph neural network model that predicts combinatorial perturbagens (sets of therapeutic targets) capable of reversing disease phenotypes. Unlike methods that learn how perturbations alter phenotypes, PDGrapher solves the inverse problem and predicts the perturbagens needed to achieve a desired response by embedding disease cell states into networks, learning a latent representation of these states, and identifying optimal combinatorial perturbations. In experiments in nine cell lines with chemical perturbations, PDGrapher identifies effective perturbagens in more testing samples than competing methods. It also shows competitive performance on ten genetic perturbation datasets. An advantage of PDGrapher is its direct prediction, in contrast to the indirect and computationally intensive approach common in phenotype-driven models. It trains up to 25× faster than existing methods, providing a fast approach for identifying therapeutic perturbations and advancing phenotype-driven drug discovery.

Abstract Image

使用因果启发神经网络的治疗扰动组合预测
表型驱动的方法通过分析区分患病和健康状态的表型特征来识别对抗疾病的化合物。在这里,我们介绍PDGrapher,这是一个因果启发的图神经网络模型,可以预测能够逆转疾病表型的组合扰动原(治疗靶点集)。与学习扰动如何改变表型的方法不同,PDGrapher解决了相反的问题,并通过将疾病细胞状态嵌入网络,学习这些状态的潜在表示,并识别最佳组合扰动,来预测实现期望响应所需的扰动原。在对9个具有化学扰动的细胞系进行的实验中,PDGrapher比其他方法在更多的测试样本中发现了有效的扰动原。它在十个遗传扰动数据集上也显示出竞争力。与表型驱动模型中常见的间接和计算密集型方法相比,PDGrapher的一个优势是它的直接预测。它的训练速度比现有方法快25倍,为识别治疗扰动和推进表型驱动的药物发现提供了快速方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nature Biomedical Engineering
Nature Biomedical Engineering Medicine-Medicine (miscellaneous)
CiteScore
45.30
自引率
1.10%
发文量
138
期刊介绍: Nature Biomedical Engineering is an online-only monthly journal that was launched in January 2017. It aims to publish original research, reviews, and commentary focusing on applied biomedicine and health technology. The journal targets a diverse audience, including life scientists who are involved in developing experimental or computational systems and methods to enhance our understanding of human physiology. It also covers biomedical researchers and engineers who are engaged in designing or optimizing therapies, assays, devices, or procedures for diagnosing or treating diseases. Additionally, clinicians, who make use of research outputs to evaluate patient health or administer therapy in various clinical settings and healthcare contexts, are also part of the target audience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信